Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay)

被引:192
作者
Jiang, ZD
Lowe, B
Verenkar, MP
Ashley, D
Steffen, R
Tornieporth, N
von Sonnenburg, F
Waiyaki, P
DuPont, HL
机构
[1] Univ Texas, Houston Sch Publ Hlth, Ctr Infect Dis, Houston, TX 77030 USA
[2] St Lukes Episcopal Hosp, Houston, TX 77030 USA
[3] Baylor Coll Med, Houston, TX 77030 USA
[4] Kenya Govt Med Res Ctr, Ctr Geog Med Res, Kilifi, Kenya
[5] Kenya Govt Med Res Ctr, Nairobi, Kenya
[6] Goa Med Coll, Bambolin, India
[7] Minist Hlth, Western Area Hlth Adm, Kingston, Jamaica
[8] Univ Zurich, Travel Clin, Zurich, Switzerland
[9] GlaxoSmithKline Biol, Rixensart, Belgium
[10] Univ Munich, Dept Infect Dis & Trop Med, Munich, Germany
关键词
D O I
10.1086/338834
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Stools from tourists from Europe and North America who acquired diarrhea in Mombasa (Kenya), Goa (India), or Montego Bay (Jamaica) were examined for enteric pathogens. Entero-toxigenic Escherichia coli (ETEC) was the most common pathogen (25%) identified in the 3 locations. Isolation of Shigella species was more frequent in Goa and Mombasa than in Montego Bay (10%, 9%, and 0.3%, respectively; P <.005). Viruses (rotaviruses and enteric adenoviruses) were found in 9% of travelers to the 3 areas. Of 275 ETEC isolates in this study, 158 (57%) produced a defined colonization factor antigen (CFA). Coli surface 6 (CS6) was the most frequent and was found in 41%-52% of CFA/CS-positive ETEC isolates. The frequency of resistance among bacterial enteropathogens to traditional antimicrobial agents was particularly high throughout the study period in all 3 regions. Quinolones were active against the bacterial enteropathogens in the 3 sites.
引用
收藏
页码:497 / 502
页数:6
相关论文
共 24 条
  • [1] Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world
    Adachi, JA
    Jiang, ZD
    Mathewson, JJ
    Verenkar, MP
    Thompson, S
    Martinez-Sandoval, F
    Steffen, R
    Ericsson, CD
    DuPont, HL
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 32 (12) : 1706 - 1709
  • [2] AGUERO ME, 1985, J CLIN MICROBIOL, V22, P576
  • [3] TRIMETHOPRIM SULFAMETHOXAZOLE REMAINS ACTIVE AGAINST ENTEROTOXIGENIC ESCHERICHIA-COLI AND SHIGELLA SPECIES IN GUADALAJARA, MEXICO
    BANDRES, JC
    MATHEWSON, JJ
    ERICSSON, CD
    DUPONT, HL
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1992, 303 (05) : 289 - 291
  • [4] COLONIZATION FACTORS OF ENTEROTOXIGENIC ESCHERICHIA-COLI ISOLATED FROM CHILDREN WITH DIARRHEA IN ARGENTINA
    BINSZTEIN, N
    JOUVE, MJ
    VIBOUD, GI
    MORAL, LL
    RIVAS, M
    ORSKOV, I
    AHREN, C
    SVENNERHOLM, AM
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (09) : 1893 - 1898
  • [5] BLACK RE, 1990, REV INFECT DIS, V12, pS73
  • [6] Improved detection of enterotoxigenic Escherichia coli among patients with travelers' diarrhea, by use of the polymerase chain reaction technique
    Caeiro, JP
    Estrada-Garcia, MT
    Jiang, ZD
    Mathewson, JJ
    Adachi, JA
    Steffen, R
    DuPont, HL
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (06) : 2053 - 2055
  • [7] TRAVELERS DIARRHEA - APPROACHES TO PREVENTION AND TREATMENT
    ERICSSON, CD
    DUPONT, HL
    [J]. CLINICAL INFECTIOUS DISEASES, 1993, 16 (05) : 616 - 624
  • [8] TRAVELERS DIARRHEA AND TOXIGENIC ESCHERICHIA-COLI
    GORBACH, SL
    KEAN, BH
    EVANS, DG
    EVANS, DJ
    BESSUDO, D
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (18) : 933 - 936
  • [9] CRYPTOSPORIDIOSIS ASSOCIATED WITH TRAVELING AND GIARDIASIS
    JOKIPII, L
    POHJOLA, S
    JOKIPII, AMM
    [J]. GASTROENTEROLOGY, 1985, 89 (04) : 838 - 842
  • [10] USE OF AZITHROMYCIN FOR THE TREATMENT OF CAMPYLOBACTER ENTERITIS IN TRAVELERS TO THAILAND, AN AREA WHERE CIPROFLOXACIN RESISTANCE IS PREVALENT
    KUSCHNER, RA
    TROFA, AF
    THOMAS, RJ
    HOGE, CW
    PITARANGSI, C
    AMATO, S
    OLAFSON, RP
    ECHEVERRIA, P
    SADOFF, JC
    TAYLOR, DN
    [J]. CLINICAL INFECTIOUS DISEASES, 1995, 21 (03) : 536 - 541